openPR Logo
Press release

Pompe Disease Global Market Analysis, Trends, Growth, Research And Forecast 2033

06-04-2024 02:44 PM CET | Health & Medicine

Press release from: The Business research company

Pompe Disease Global Market

Pompe Disease Global Market

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Pompe Disease Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $2.13 billion In 2028 At A CAGR Of 5.3%.

The pompe disease market size has grown steadily in recent years. It will grow from $1.66 billion in 2023 to $1.73 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increased awareness and diagnosis, orphan drug designation and incentives, global collaborations and research initiatives, patient advocacy and support groups..

The pompe disease market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to continued research and development, expansion of newborn screening programs, advancements in gene therapy, increasing global investment in rare diseases, patient-centric drug development, expansion of clinical trials and research initiatives, market emphasis on personalized medicine approaches. Major trends in the forecast period include product innovation, technological advancements, implementation of patient support programs, growing adoption of telemedicine for patient management, collaborations for expanded access programs..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11906&type=smp

Pompe Disease Market Major Segments
The pompe disease market covered in this report is segmented -

1) By Type: Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Form, Other Types
2) By Diagnosis: Blood Test, Genetic Test, Prenatal Test, Other Diagnosis
3) By Route of Administration: Oral, Parenteral, Other routes of administrations
4) By Therapy Type: Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Gene Therapy, Other Therapies
5) By End Users: Hospitals / Clinics, Pharmaceuticals, Researchers, Other End-Users

Key Driver - Rising Prevalence Of Pompe Disease Fuels Market Expansion

The increase in the prevalence of pompe disease is expected to propel the growth of the pompe disease market. Pompe disease, also known as glycogen storage disease type II or acid maltase deficiency, is a rare genetic disorder characterized by the build-up of glycogen (a complex sugar molecule) in various body tissues, particularly in muscles and organs. Treatments for pompe disease include protein replacement therapy, alglucosidase alfa, and Nexviazyme for intravenous infusion. A rise in pompe disease cases will contribute to the growth of the pompe disease market. For instance, in June 2022, according to the European Medicines Agency Highlights, a Europe-based intergovernmental organization, there are roughly 224 infantile-onset, 471 juvenile-onset, and 20,490 adult-onset persons in Europe with mutations that potentially cause Pompe disease based on the maximum birth incidence of 11.6 per 100,000. Therefore, the increase in the prevalence of pompe disease is driving the growth of the pompe disease market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=11906&type=smp

Prominent Trend - Innovative Therapies Transforming Pompe Disease Market Dynamics

Product innovations are a key trend gaining popularity in the pompe disease market. Major companies operating in the pompe disease market are adopting innovations to sustain their position in the market. For instance, in September 2023, Amicus Therapeutics, a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for Pombiliti (cipaglucosidase alfa-atga) and Opfolda (miglustat) 65 mg capsules. This two-component therapy is designed for adults with late-onset Pompe disease (LOPD) weighing ≥40 kg. Pombiliti and Opfolda are a unique combination, with Pombiliti being a recombinant human GAA enzyme (rhGAA) designed for increased uptake into muscle cells and Opfolda serving as an enzyme stabilizer to stabilize the enzyme in the blood. This FDA approval underscores the significance of advancements in science and medicine.

Pompe Disease Market Players
Major companies operating in the pompe disease market report are F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Becton, Dickinson and Company, Astellas Pharma Inc., BioMérieux SA, BioMarin Pharmaceutical Inc., Nova Biomedical Corporation, Instrumentation Laboratory Company, Amicus Therapeutics Inc., Sekisui Diagnostics LLC, Spark Therapeutics Inc., Sangamo BioSciences Inc., Asklepios BioPharmaceutical Inc., Avrobio Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., Audentes Therapeutics Inc., Rougine Darou, Genethon, Maze Therapeutics Inc., Avidity Biosciences Inc., EpiVax Inc., M6P Therapeutics, Oxyrane UK Limited, Valerion Therapeutics LLC

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the pompe disease market in 2023. The regions covered in the pompe disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Pompe Disease Market Report Structure
3. Pompe Disease Market Trends And Strategies
4. Pompe Disease Market - Macro Economic Scenario
5. Pompe Disease Market Size And Growth
…..
27. Pompe Disease Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pompe Disease Global Market Analysis, Trends, Growth, Research And Forecast 2033 here

News-ID: 3525449 • Views:

More Releases from The Business research company

Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billion by 2029
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. What Are the Dermal Regeneration Market Size Forecast for 2025? In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025? In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billion by 2029
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025? The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth? The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate

All 5 Releases


More Releases for Pompe

Pompe Disease Market Trends That Will Shape the Next Decade: Insights from Innov …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Pompe Disease Market Size By 2025? The market scale for Pompe disease has seen a consistent growth over the past few years. Its size is expected to increase from the current $1.74 billion in 2024 to about $1.8 billion in 2025, exhibiting a compound annual
Leading Element Driving Change in the Pompe Disease Market in 2025: Rising Preva …
How Are the key drivers contributing to the expansion of the pompe disease market? The surge in the occurrence of Pompe disease, which is also known as glycogen storage disease type II or acid maltase deficiency, is anticipated to contribute significantly to the expansion of the Pompe disease market. This rare genetic condition is marked by an accumulation of glycogen, or a complex sugar molecule, in muscles and different body tissues.
Pompe Disease Therapeutics and Treatment Market Report 2024
"The Business Research Company recently released a comprehensive report on the Global Pompe Disease Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Pompe Disease Treatment Drugs, Pipeline Insight Report 2024
DelveInsight's, "Pompe Disease Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pompe Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Pompe
Gaucher & Pompe Diseases Enzyme Replacement Therapy (ERT) Market - Restoring Bal …
Newark, New Castle, USA: The "Gaucher & Pompe Diseases Enzyme Replacement Therapy (ERT) Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gaucher & Pompe Diseases Enzyme Replacement
Pompe Disease Therapeutic Market - Increasing prevalence of pompe disease in man …
Pompe Disease Therapeutic Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Pompe Disease Therapeutic Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. This comprehensive